Medicare Rx Regs Will Be Final By February, CMS Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Internal deadline would give potential drug plan sponsors time to consider their role in Medicare and prepare bids, CMS official tells FDLI teleconference. CMS will screen potential bidders for Part D criteria through request for proposals process.
You may also be interested in...
Medicare Rx Formulary Design Should Prevent Risk Selection – Rep. Waxman
CMS faces a dilemma in trying to satisfy both plan providers and manufacturers, Waxman acknowledges, and says that the agency should ensure that formularies do not discourage use by high-cost beneficiaries.
Medicare Rx Formulary Design Should Prevent Risk Selection – Rep. Waxman
CMS faces a dilemma in trying to satisfy both plan providers and manufacturers, Waxman acknowledges, and says that the agency should ensure that formularies do not discourage use by high-cost beneficiaries.
Medicare Rx Implementing Regs Open For Comment Until October
Proposed rules for Title I (Part D drug benefit) and Title II (Medicare Advantage) of the Medicare Modernization Act are unveiled at an HHS press conference. Final regs will be done by early 2005, "if not sooner," CMS Administrator McClellan says.